The global market for personalized medicine technology is projected to be $14.4 billion in 2009 and is expected to reach $29.2 billion in 2014, for a compound annual growth rate (CAGR) of 15.2% Pharmacogenomics is a major revenue generating market, contributing about 28.7% to the total personalized medicine market in 2009, at $4.1 billion; this should reach $9.5 billion in 2014, for a CAGR of 18% The point-of-care market has the second largest share of the market, at $2.7 billion in 2009. This is expected to increase to $5.1 billion in 2014, for a CAGR of 18%.

Study Goals and Objectives

To measure the personalized medicine market, which has experienced high growth year to year.
To analyze the current personalized medicine business model and to evaluate the commercial use of the personalized medicine technology platform.
To analyze individual submarkets for personalized medicine in terms of technology, products, services, application areas and geography.
To estimate the growth rate of all the submarkets based on various factors.
To analyze and forecast the market data for each subsegment for the next 5 years.
To define and identify the high growth markets among the subsegments of the personalized medicine market.
To strategically discuss the trends and market opportunities for the various stakeholders in identifying the focus areas within the market.
To strategically analyze the competitive landscape and the participation of all the top companies in the market.

Reasons For Doing The Study

Personalized diagnosis and treatment - or personalized medicine - is the most recent trend in the multibillion - dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order to improve the drug development process and also to speed up the approval of new drugs.

According to the industry consensus, personalized medicine will not only form an integral part of mainstream medicine in the next few years, it is also expected to reform the development, testing, marketing and prescription of drugs during the next decade. The big pharmaceutical companies eventually will change their tried - and - tested blockbuster business model to more - targeted and effective healthcare solutions.

Several diagnostic and life - science companies have yet to tap the complete personalized medicine market, which is experiencing rapid growth all over the world. A detailed study of the different subsegments within personalized medicine is required for existing and new players to develop new strategies to harness the expanding market. This research report will address this need by analyzing market trends, new and available opportunities and the current competitive landscape in the personalized medicine market.

Scope of Report

The personalized medicine market is segmented according to products, services, technology, applications and geography. Each section will provide market data, market drivers, trends and opportunities, top - selling products and the profiles of key market players. Along with the company profiles, the report will feature market tables to provide complete insight on the market. All market tables are categorized according to products, services, technologies, applications and geography. The report also highlights the strategic issues involved in tapping the personalized medicine market, which is reporting double - digit growth year - on - year.

Intended Audience

The intended audience includes all the stakeholders (except end - users) of the personalized medicine market: Equipment manufacturers, specialized technology providers, pharmaceutical companies, biotechnology companies and diagnostic companies and physicians.

This report provides all the necessary information for all industry participants to understand the market scenario and develop marketing strategies based on the opportunities highlighted here. The market data and forecasts made up to the year 2014 explain the demand for products and services.

Information Sources and Methodology

The market data will consist of aggregate revenues generated from all submarkets within the personalized medicine market. We have analyzed existing and new technologies in the personalized medicine market, and studied the new products introduced in these categories. The report examines all the application areas and also identifies the unexplored markets. We have researched all technology patents over the last 5 years. We have also analyzed the key market developments of the top companies, and provided profiles for each of these players. Information has been collected through paid and unpaid secondary sources; and primary research was conducted to get a more in - depth understanding of the facts and facets of the industry.

Chapter-1: Summary
- Summary Table Global Market Forecast for Personalized Medicine, by Technology, through 2014 ($ Millions)
- Summary Figure Global Market Forecast for Personalized Medicine, by Technology, 2007-2014 ($ Millions) 5
Chapter-2: Market Overview
- Market Overview
- Figure 1 Personalized Medicine vs Conventional Treatments
- Figure 2 Focus of Personalized Medicine
- Changing Trends: from Blockbuster Model to Personalized Model
- Figure 3 Personalized Medicine vs Blockbuster Drugs
- Major Market Drivers
- Accuracy and Preventive Diagnosis
- Cost - Effective in Long Run
- Recuperative Benefits
- More Effective than Conventional Treatments
- Market Restraints
- Reluctance among Pharmaceutical Companies
- Legal Issues Due to Intellectual Property Rights
- Lack of Insurance Coverage
- Figure 4 Major Market Trends in Personalized Medicine
- Stakeholders' Opportunities
- Figure 5 Participation of Stakeholders
- Table 1 Global Market for Stakeholders, through 2014 ($ Millions)
- Defining The Overall Personalized Medicine Market
- Figure 6 Market Structure for Personalized Medicine
- Defining The Personalized Medicine Technology Market
- Figure 7 Global Market Forecast for Personalized Medicine, by Technology, 2007-2014 ($ Millions)
- Defining The Personalized Medicine Products and Services Market
- Table 2 Global Personalized Medicine Market by Products and Services, through 2014 ($ Millions)
- Defining The Personalized Medicine Applications Market
- Table 3 Global Market Forecast for Personalized Medicine, by Application, through 2014 ($ Millions)
- Defining The Personalized Medicine Market by Geography
- Figure 8 Global Markets for Personalized Medicine, 2009 (%)
- Patent Analysis
- Figure 9 Numbers of Patents Issued, Jan. 2004 - Apr. 2009 20
Chapter-3: Global Personalized Medicine Market by Technology
- Global Personalized Medicine Market by Technology
- Figure 10 Positioning Various Technologies in The Market for Personalized Medicine
- Analysis of Patents by Technology
- Figure 11 Share of Patents by Technology (%)
- Global Pharmacogenomics Market in Personalized Medicine
- Table 4 Global Pharmacogenomics Market in Personalized Medicine by Products and Services, through 2014 ($ Millions)
- Table 5 Global Pharmacogenomics Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Increased Health Awareness and Preventive Diagnosis to Boost The Demand for Pharmacogenomics
- Increased Revenue Opportunities for Diagnostic and Drug Companies
- Enhanced Treatment and Better Drug Efficacy Rate
- Market Restraints
- Intellectual Property Rights Problem
- Legal Issues within Nations
- Pharmacogenomic Services Market
- Table 6 Global Pharmacogenomics Market in Personalized Medicine by Services, through 2014 ($ Millions)
- Table 7 Global Pharmacogenomics Services Market in Personalized Medicine, through 2014 ($ Millions)
- Global Market for Snp Genotyping
- Cost Effective Sequencing Boosts Demand
- Oligopoly Market Restrains Entry of New Companies
- Global Market for Snp Genotyping Services
- Table 8 Global Snp Genotyping Market in Personalized Medicine by Diagnosis Methods, through 2014 ($ Millions)
- Table 9 Global Snp Genotyping Market in Personalized Medicine by Services, through 2014 ($ Millions)
- Global Market for Snp Genotyping Products
- Table 10 Global Snp Genotyping Market in Personalized Medicine by Products, through 2014 ($ Millions)
- Major Companies and Products
- Table 11 Major Products in Snp Genotyping
- Global Market for Pharmacogenomic Drug Discovery and Delivery
- Table 12 Global Drug Discovery and Delivery Market in Pharmacogenomics, through 2014 ($ Millions)
- Market for Ssr - Based Diagnosis
- Table 13 Global Ssr Based Diagnosis Market in Personalized Medicine, through 2014 ($ Millions)
- Market for Vntrs - Based Diagnosis
- Table 14 Global Vntr Based Diagnosis Market in Personalized Medicine, through 2014 ($ Millions)
- Global Market for Pharmacogenomic Therapy
- Table 15 Global Pharmacogenomic Therapy Market in Personalized Medicine, through 2014 ($ Millions)
- Global Market for Other Pharmacogenomic Services
- Top Companies
- Table 16 Major Companies and Respective Products in Pharmacogenomic Services
- Pharmacogenomic Products Market
- Table 17 Global Pharmacogenomics Market in Personalized Medicine by Products, through 2014 ($ Millions)
- Table 18 Global Pharmacogenomics Products Market in Personalized Medicine, through 2014 ($ Millions)
- Markets for Pharmacogenomic Drugs
- Table 19 Global Pharmacogenomics Drugs Market in Personalized Medicine, through 2014 ($ Millions)
- Markets for Equipment in Pharmacogenomics
- Table 20 Global Pharmacogenomics Equipment Market in Personalized Medicine, through 2014 ($ Millions)
- Major Techniques
- Table 21 Global Market for Major Pharmacogenomic Techniques in Personalized Medicine, through 2014 ($ Millions)
- Global Pharmacoproteomics Market in Personalized Medicine
- Table 22 Global Pharamcoproteomics Market in Personalized Medicine by Products and Services, through 2014 ($ Millions)
- Table 23 Global Pharamcoproteomics Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Superior Diagnostic Results with Protein Studies
- High Revenue Generation Attracts More Market Players
- Market Restraints
- Continuous Change in Protein Formation Makes IT A Costly Treatment
- Top Companies
- Table 24 Major Products in Pharmacoproteomics
- Market for Pharmacoproteomics Services
- Table 25 Global Pharamcoproteomics Market in Personalized Medicine by Services, through 2014 ($ Millions)
- Table 26 Global Pharamcoproteomics Services Market in Personalized Medicine, through 2014 ($ Millions)
- Pharmacoproteomic Products
- Table 27 Global Pharamcoproteomics Market in Personalized Medicine by Products, through 2014 ($ Millions)
- Table 28 Global Pharamcoproteomics Products Market in Personalized Medicine, through 2014 ($ Millions)
- Table 29 Global Pharamcoproteomics Drugs Market in Personalized Medicine, through 2014 ($ Millions)
- Major Technologies
- Table 30 Global Pharamcoproteomics Market in Personalized Medicine by Major Technology, through 2014 ($ Millions)
- Global Stem Cell Therapy Market in Personalized Medicine
- Table 31 Global Stem Cell Therapy Market in Personalized Medicine by Technology, through 2014 ($ Millions)
- Table 32 Global Stem Cell Therapy Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Highly Untapped Market
- Multiple Treatments with One Stem Cell
- Government Appreciation in The U.S. for Embryonic Stem Cell Research
- Market Restraints
- Time Consuming Treatment
- Side Effects
- Top Companies
- Table 33 Main Companies and Products in Stem Cell Therapy
- Table 34 Recent Products in Stem Cell Therapy
- Adult Stem Cell Therapy
- Table 35 Global Adult Stem Cell Therapy Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Enhanced Treatment for Spinal Cord Injury and Diseases Such as Cancer
- Federal Funding in The U.S. for Adult Stem Cell Therapy
- Market Restraints
- Stem Cell Therapy Requires Frequent Treatment
- Embryonic Stem Cell Therapy
- Market Drivers
- Enhanced Curative Potential Will Attract More Customers
- Sufficient Knowledge on Many Ranges of Stem Cells
- Market Restraints
- Religious and Political Issues
- Other Techniques
- Global Point of Care Market in Personalized Medicine
- Table 36 Global Point of Care Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Fast, Easy, and Exact Personalized Care
- Developed Technology Paves The Way for A Developed Market
- Market Restraints
- Time - Consuming Realization of Insurance Policies
- Top Companies and Their Products
- Table 37 Top Companies and Their Products in Point of Care
- Table 37 (Continued)
- Table 38 New Technologies in Point of Care
- Global Metabolomics Market in Personalized Medicine
- Table 39 Global Metabolomics Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Enhanced R&d in Drug Discovery Process
- Competitive Advantage and Less Regulatory Hurdles in Final Drug Delivery
- Market Restraints
- Adopted by Fewer Companies
- Top Companies
- Table 40 Major Companies and Their Products
- Global Pharmacogenetics Market in Personalized Medicine
- Table 41 Global Pharmacogenetics Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Preventive and Curative Treatments Use Pharmacogenetic Technique
- Enhanced Drugs for Diseases Such as Cancer/Cardiovascular Problems
- Market Restraints
- High Cost
- Top Companies
- Table 42 Main Products in Pharmacogenetics
- Global Pharmacokinetics Market in Personalized Medicine
- Table 43 Global Pharmacokinetics Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Better Evaluation of The Body' S Response to The Drug
- Quantitative Results Make IT User Friendly for Patients
- Untapped Market Means Potential Growth for Companies
- Market Restraints
- Assumptions of Mathematical Models Can Give Unwanted Results
- Costly Treatment Hampers Market Growth
- Top Companies
- Table 44 Main Products in Pharmacokinetics
- Global Pharmacodynamics Market in Personalized Medicine
- Table 45 Global Pharmacodynamics Market in Personalized Medicine, through 2014 ($ Millions)
- Table 45 Global Pharmacodynamics Market in Personalized Medicine, through 2014 ($ Millions) (Contd) 59
Chapter-4: Global Market for Personalized Medicine by Services
- Table 46 Global Personalized Medicine Market by Services, through 2014 ($ Millions)
- Table 47 Global Personalized Medicine Services Market, through 2014 ($ Millions)
- Global Market for Drug Development/Drug Delivery Service
- Table 48 Global Drug Development and Delivery Market in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Shift of Trend from Blockbuster Drugs to Tailored Drugs
- Higher Efficacy of Drugs with Personalized Medicine
- Market Restraints
- Expensive Drugs in Comparison to Blockbuster Drugs
- Top Companies
- Global Market for Diagnosis
- Table 49 Global Personalized Medicine Diagnostic Services Market, by Technology, through 2014 ($ Millions)
- Table 50 Global Personalized Medicine Diagnostic Services Market, through 2014 ($ Millions)
- Pharmacogenomics Based Diagnosis
- Table 51 Global Pharmacogenomic Diagnostic Services Market, through 2014 ($ Millions)
- Market Drivers
- Individual Gene Tests Are Increasing Revenues for Diagnostic Players
- Market Restraints
- Rapidly Evolving Technology Is Not Aligned to Fixed Regulatory System
- Pharmacoproteomics Based Diagnosis
- Table 52 Global Pharmacoproteomic Diagnostic Services Market, through 2014 ($ Millions)
- Market Drivers
- in - Depth Research Provides A Lot of Information for Diagnosis
- Market Restraints
- Costly Treatment Due to Requirement of Continuous Monitoring of Changing Protein Formation
- Pharmacogenetics Based Diagnosis
- Table 53 Global Pharmacogenetic Diagnostic Services Market, through 2014 ($ Millions)
- Global Market for Monitoring and Therapy Services
- Monitoring Services
- Table 54 Global Personalized Medicine Monitoring Services Market, through 2014 ($ Millions)
- Therapeautic Services
- Table 55 Global Personalized Medicine Therapeutic Services Market, through 2014 ($ Millions)
- Global Market for Other Services
- Table 56 Global Other Services Market in Personalized Medicine, through 2014 ($ Millions) 70
Chapter-5: Global Market for Personalized Medicine by Products
- Table 57 Global Personalized Medicine Market by Products, through 2014 ($ Millions)
- Table 58 Global Personalized Medicine Products Market, through 2014 ($ Millions)
- Global Personalized Medicine Market for Diagnostics Equipment
- Table 59 Global Market for Diagnostic Equipment in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Increased Demand for Genetic and Proteomic Tests
- Market Restraints
- Fast Changing Technology
- Table 60 Global Market for Monitoring and Therapeutic Equipment in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Improved Technology along with Low - Cost Monitoring and Therapeutic Devices
- Global Personalized Medicine Market for Bioinformatics Products
- Table 61 Global Market for Bioinformatics in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Bioinformatics Reduces Cost of Drug Development
- Market Restraints
- High Initial Investment Hinders Small and Medium Sized Companies
- Global Personalized Medicine Market for Drugs
- Table 62 Global Market Forecast for Drugs in Personalized Medicine by Products, through 2014 ($ Millions)
- Table 63 Global Market Forecast for Drugs in Personalized Medicine, through 2014 ($ Millions)
- Drug Stages
- Figure 12 Product Life Cycle for Personalized Medicine Products
- Gleevec
- Table 64 Global Market Forecast for Gleevac in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Higher Efficacy of Gleevec Gives IT A Large Consumer Base
- Gleevec as A Pill Makes IT Easy to Consume
- Assistance for Reimbursement from Insurance Companies
- Market Restraints
- High Drug Cost Is Affecting Market Growth
- Inherent Side Effects of Gleevec
- Herceptin
- Table 65 Global Market Forecast for Herceptin in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Enhanced Treatment with Reduced Risk of Reoccurrence of Breast Cancer
- Market Restraints
- Tailor Made Herceptin Still Carries Inherent Side Effects
- Ziagen
- Table 66 Global Market Forecast for Ziagen in Personalized Medicine, through 2014 ($ Millions)
- Market Drivers
- Customizable for Children
- Market Restraints
- Treatment with Ziagen Cannot Be Restarted
- Iressa and Tarceva
- Iressa
- Market Drivers
- " Iressa in Pills Makes IT User Friendly
- Market Restraints
- " Fda Ban on Iressa Is Keeping IT Away from The U.S. Market
- Tarceva
- Table 67 Global Market Forecast for Iressa & Tarceva in Personalized Medicine, through 2014 ($ Millions)
- Erbitux
- Table 68 Globol Market Forecast for Erbitux in Personalized Medicine through 2014 ($ Millions)
- Market Drivers
- Multiple Cancers Are Treated with Erbitux, Which Gives IT A Large Patient Base
- Enhanced Survival Results When Radiotherapy Is Combined with Erbitux
- Others
- Table 69 Global Market Forecast for Other Drugs in Personalized Medicine, through 2014 ($ Millions) 85
Chapter-6: Global Market for Personalized Medicine by Applications
- Global Market for Personalized Medicine by Applications
- Figure 13 Global Market Forecast for Personalized Medicine, by Application, through 2014 ($ Billions)
- Personalized Medicine Market for Cardiovascular Disease
- Table 70 Global Market Forecast for Treatment of Cardiovascular Diseases, through 2014 ($ Millions)
- Market Drivers
- Possible Preventive Measure
- Market Restraints
- Lack of Proactive Approach for Early Diagnosis
- Personalized Medicine Market for Breast Cancer
- Table 71 Global Market Forecast for Breast Cancer Treatment through 2014 ($ Millions)
- Market Drivers
- Fewer Side Effects with Personalized Medicine
- Market Restraints
- Resistance to Adopting New Methods of Treatment
- Recent Developments
- Table 72 Recent Developments in Treatment of Breast Cancer
- Personalized Medicine Market for Leukemia
- Table 73 Global Market Forecast for Leukemia Tretament through 2014 ($ Millions)
- Market Drivers
- Huge Market Potential for Leukemia
- Market Restraints
- Lack of Awareness That Surgery Is The Only Way to Treat Leukemia
- Personalized Medicine Market for Lung Cancer
- Table 74 Global Market Forecast for Lung Cancer Treatment, through 2014 ($ Millions)
- Market Drivers
- Higher Efficiency than Conventional Lung Cancer Treatment
- Availability of Drugs in The Form of Pills Makes Treatment User Friendly
- Market Restraints
- Lack of Fda Approval for Certain Personalized Drugs
- Recent Developments
- Personalized Medicine Market for Treating Hiv/Aids
- Table 75 Global Market Forecast for Aids Treatment through 2014 ($ Millions)
- Market Drivers
- Personalized Medicine Improves Life Expectancy of A Patient
- Easy Reimbursement for Aids Patients from Ngos/Government Organizations
- Market Restraints
- Lack of Awareness among Patients
- Personalized Medicine Market for Neurological Disorders
- Table 76 Global Market Forecast for Treating Neurological Disorders, through 2014 ($ Millions)
- Market Drivers
- Enhanced Treatment
- Market Restraints
- Apprehensive to Try out New Medications
- Personalized Medicine Market for Diabetes
- Table 77 Global Market Forecast for Treatment of Diabetes, through 2014 ($ Millions)
- Market Drivers
- Early Diagnosis Can Help Prevent Diabetes
- Market Restraints
- Casual Approach towards Diabetes
- Recent Developments
- Table 78 Recent Developments in Treating Diabetes
- Personalized Medicine Market for Asthma
- Table 79 Global Market Forecast for Treating Asthma, through 2014 ($ Millions)
- Market Drivers
- Every Asthma Case Is Distinct, Needs Custom - Tailored Treatment
- Asthma Treatment Needs Regular Monitoring
- Other Applications
- Table 80 Global Market Forecast for Treating Other Cancer/Tumor, through 2014 ($ Millions)
- Table 81 Global Market Forecast for Treating Other Diseases, through 2014 ($ Millions) 101
Chapter-7: Global Personalized Market by Geography
- Abbott
- Overview
- Table 97 Product Portfolio of Abbott
- Strategy
- Affymetrix
- Overview
- Table 98 Product Portfolio of Affymetrix (Microarrays)
- Table 99 Product Portfolio of Affymetrix (Reagents & Assays)
- Strategy
- Agendia Bv
- Overview
- Table 100 Product Portfolio of Agendia Bv
- Strategy
- Asuragen
- Overview
- Table 101 Product Portfolio of Asuragen
- Strategy
- Bayer Healthcare
- Table 102 Product Portfolio of Bayer Healthcare
- Strategy
- Biogen (Idec)
- Overview
- Table 103 Product Portfolio of Biogen (Idec)
- Strategy
- Bristol - Myers Squibb
- Overview
- Table 104 Product Portfolio of Bristol - Myers Squibb
- Strategy
- Celera Diagnostics
- Overview
- Table 105 Product Portfolio of Celera Diagnostics
- Table 106 New Product Development of Celera Diagnostics
- Strategy
- Cepheid
- Overview
- Table 107 Product Portfolio of Cepheid
- Strategy
- Clinical Data
- Overview
- Table 108 Product Portfolio of Clinical Data
- Table 108 (Continued)
- Strategy
- Curagen Corp
- Overview
- Table 109 Product Portfolio of Curagen Corp
- Strategy
- Dako Denmark A/S
- Overview
- Table 110 Product Portfolio of Dako Denmark A/S
- Table 110 (Continued)
- Strategy
- Decode Genetics
- Overview
- Table 111 Product Portfolio of Decode Genetics
- Table 112 New Product Development of Decode Genetics
- Strategy
- DNA Direct, Inc
- Overview
- Table 113 Product Portfolio of DNA Direct, Inc
- Strategy
- Dxs Ltd
- Overview
- Table 114 Product Portfolio of Dxs Limited
- Strategy
- Exact Sciences Corp
- Overview
- Table 115 Product Portfolio of Exact Sciences Corp
- Strategy
- Exagen Diagnostics
- Overview
- Table 116 Product Portfolio of Exagen Diagnostics
- Gene Logic (An Ocimum Biosolutions Company)
- Overview
- Table 117 Product Portfolio of Gene Logic
- Table 117 (Continued)
- Strategy
- Genelex Corp
- Overview
- Table 118 Product Portfolio of Genelex Corp
- Table 118 (Continued)
- Table 118 (Continued)
- Strategy
- Genentech, Inc
- Overview
- Table 119 Product Portfolio of Genentech, Inc
- Table 119 (Continued)
- Strategy
- Genomic Health, Inc
- Overview
- Table 120 Product Portfolio of Genomic Health Inc
- Strategy
- Gen - Probe
- Overview
- Table 121 Product Portfolio of Gen - Probe
- Table 122 New Product Development of Gen - Probe
- Strategy
- Genta
- Overview
- Table 123 Product Portfolio of Genta
- Table 124 New Product Development of Genta
- Strategy
- Glaxosmithkline
- Overview
- Table 125 Product Portfolio of Glaxosmithkline
- Strategy
- Illumina
- Overview
- Table 126 Product Portfolio of Illumina
- Table 126 (Continued)
- Strategy
- Luminex Corp
- Overview
- Table 127 Product Portfolio of Luminex Corp
- Millennium
- Overview
- Table 128 Product Portfolio of Millennium
- Strategy
- Monogram Biosciences
- Overview
- Table 129 Product Portfolio of Monogram Biosciences
- Strategy
- Myriad Genetics, Inc
- Overview
- Table 130 Product Portfolios of Myriad Genetics
- Table 131 New Product Development of Myriad Genetics
- Strategy
- Nanogen
- Overview
- Table 132 Product Portfolio of Nanogen
- Table 132 (Continued)
- Strategy
- Novartis
- Overview
- Table 133 Product Portfolio of Novartis
- Strategy
- Osmetech Plc
- Overview
- Table 134 Product Portfolio of Wyeth
- Strategy
- Promega
- Overview
- Table 135 Product Portfolio of Promega
- Strategy
- Qiagen
- Overview
- Table 136 Product Portfolio of Qiagen
- Table 136 (Continued)
- Strategy
- Roche Diagnostics
- Overview
- Table 137 Product Portfolio of Roche Diagnostics
- Strategy
- Siemens Healthcare Diagnostics
- Overview
- Table 138 Product Portfolio of Siemens Healthcare Diagnostics
- Strategy
- Target Discovery, Inc
- Overview
- Table 139 Product Portfolio of Target Discovery
- Strategy
- Ventana Medical Systems, Inc
- Overview
- Table 140 Product Portfolio of Ventana Medicalsystems, Inc
- Strategy
- Wyeth
- Overview
- Table 141 Product Portfolio of Wyeth
- Strategy
- Appendix
- Patents Issued in U.S

Pharmaceutical Market Research

Personalized Medicine: Technologies and the Global Market